Objective Promising evidence suggests beneficial health effects of arabinogalactan, but little
is known about the effect of this non-digestible carbohydrate on the gut microbiota, a crucial …

Recently, the intestinal microbiota has been emphasised as an important contributor to the
development of metabolic syndrome. Dietary fibre may exert beneficial effects through …

Background Variability in the health effects of dietary fiber might arise from inter-individual
differences in the gut microbiota's ability to ferment these substrates into beneficial …

Intestinal fibrosis is a long–term complication of inflammatory bowel diseases (IBD).
Changes in microbial populations have been linked with the onset of fibrosis and some food …

Background & aims Obesity and metabolic diseases are associated with alterations in
microbial composition and impaired gut barrier. Previous in vitro and animal studies have …

Abstract The Mucosal-Simulator of the Human Intestinal Microbial Ecosystem (SHIME) was
used to differentiate the gut microbial fermentation of arabinogalactan (AG) and starch …

Background Interactions between the microbial flora of the intestine and the human host
play a critical role in maintaining intestinal health and in the pathophysiology of a wide …

Background & aims Gut microbiota composition is linked to obesity and metabolic syndrome.
The nutrients and doses required to modulate the gut microbiota towards beneficially …

Objectives: Arabinogalactan (AG) is a non-digestible soluble dietary fiber that resists
hydrolytic enzyme action and enters the large bowel intact where it is fermented by resident …

Insufficient dietary fiber intake can negatively affect the intestinal microbiome and, over time,
may result in gut dysbiosis, thus potentially harming overall health. This randomized …